Screening for nutritional risk in hospitalized children with liver disease

Tiantian Song1, Ying Mu1, Xue Gong1

  • 1Department of Clinical Nutrition, The 302 Military Hospital of China, Beijing, China.

Insights

Malnutrition is common in hospitalized children with liver disease, with high nutritional risk at admission. Nutritional support rates are low, despite links to longer hospital stays and increased costs.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Nutrition
  • Hepatology

Background:

  • Malnutrition significantly impacts morbidity and mortality in pediatric liver disease.
  • Assessing nutritional status and risk is crucial for hospitalized children with liver conditions.

Purpose of the Study:

  • To determine the prevalence of malnutrition and high nutritional risk in hospitalized children with liver disease.
  • To evaluate the rate of in-hospital nutritional support and its impact on outcomes.

Main Methods:

  • A cohort of 2,874 children (1-17 years) with liver disease was analyzed.
  • Malnutrition was screened using anthropometric measures; nutritional risk was assessed with the STRONGkids tool.
  • Serum albumin, prealbumin, nutritional support rates, length of stay, and hospital costs were compared across risk groups.

Main Results:

  • Overall malnutrition prevalence was 38.6%; 20.0% had high nutritional risk.
  • Malnutrition was significantly higher in the high-risk group (67.9%) versus moderate-risk (31.3%).
  • Children with high nutritional risk experienced longer hospital stays and higher costs, with low rates of nutritional support (8.9%).

Conclusions:

  • High prevalence of malnutrition and nutritional risk exists in hospitalized children with liver disease.
  • Serum albumin and prealbumin effectively differentiate nutritional risk levels.
  • In-hospital nutritional support is underutilized, necessitating standardization to improve patient outcomes and reduce healthcare costs.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
225
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
658
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
950
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.2K